cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Eli Lilly And Company
274 own
175 watching
Current Price
$805.15
$-16.04
(-1.95%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
805,701.55M
52-Week High
52-Week High
966.09998
52-Week Low
52-Week Low
446.56000
Average Volume
Average Volume
3.39M
Dividend Yield
Dividend Yield
0.012415
P/E Ratio
P/E Ratio
40.4129
iconMarket Capitalization805,701.55M
icon52-Week High966.09998
icon52-Week Low446.56000
iconAverage Volume3.39M
iconDividend Yield0.012415
iconP/E Ratio40.4129
What does the Eli Lilly And Company do?
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The company offers endocrinology products to treat diabetes; osteoporosis in postmenopausal women and men; human growth hormone deficiency and pediatric growth conditions; and testosterone deficiency. It also provides neuroscience products for the treatment of depressive disorders, diabetic peripheral neuropathic pain, anxiety disorders, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorders; depressive, obsessive-compulsive, bulimia nervosa, and panic disorders; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains. In addition, the company offers products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine headaches. Further, it provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry; and chewable tablets that kill fleas and prevent flea infestations, and heartworm diseases, as well as controls intestinal parasite infections. Additionally, the company offers vaccinev to prevent Lyme disease, bronchial infections, rabies, and various infectious diseases in dogs, cats, and horses. It has collaboration agreements with Daiichi Sankyo Co., Ltd., Incyte Corporation, Pfizer Inc., AstraZeneca, and William Sansum Diabetes Center. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Read More
How much money does Eli Lilly And Company make?
News & Events about Eli Lilly And Company.
Ticker Report
1 year ago
Walkner Condon Financial Advisors LLC purchased a new position in Eli Lilly and Company (NYSE:LLY Free Report) during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 593 shares of...
Zolmax
1 year ago
Stonegate Investment Group LLC boosted its position in shares of Eli Lilly and Company (NYSE:LLY Free Report) by 1,794.8% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 67,056 shares of the companys stock after buying an ...
Business Wire
1 year ago
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Sigilon Therapeutics, Inc. (NasdaqGS: SGTX) to Eli Lilly and Company (NYSE: LLY). Under the terms of the proposed transaction, shareholders...
Zero Hedge
1 year ago
Thyroid Cancer Concerns Raised Regarding Active Ingredient In Popular Drugs Ozempic And Wegovy Authored by Harry Lee via The Epoch Times (emphasis ours), The European Medicines Agency (EMA) has issued a drug safety signal (pdf) regarding the potential risk of thyroid cancer associated with ...
TipRanks Financial Blog
1 year ago
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sanofi (SNYNF Research Report) and Eli LillyCo ... Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sanofi (SNYNF Research Report) and Eli Lilly Co...
Frequently Asked Questions
Frequently Asked Questions
What is Eli Lilly And Company share price today?
plus_minus_icon
Can Indians buy Eli Lilly And Company shares?
plus_minus_icon
How can I buy Eli Lilly And Company shares from India?
plus_minus_icon
Can Fractional shares of Eli Lilly And Company be purchased?
plus_minus_icon
What are the documents required to start investing in Eli Lilly And Company stocks?
plus_minus_icon
What is today’s traded volume of Eli Lilly And Company?
plus_minus_icon
What is today’s market capitalisation of Eli Lilly And Company?
plus_minus_icon
What is the 52-Week High and Low Range of Eli Lilly And Company?
plus_minus_icon
What percentage is Eli Lilly And Company down from its 52-Week High?
plus_minus_icon
What percentage is Eli Lilly And Company up from its 52-Week Low?
plus_minus_icon
Current Price
$805.15
$-16.04
(-1.95%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
AbbVie Inc.
AbbVie Inc.
$185.19
$3.02 (1.66 %)
Novartis AG
Novartis AG
$110.28
$0.35 (0.32 %)
Merck & Co. Inc.
Merck & Co. Inc.
$125.30
$-0.55 (-0.44 %)
Johnson & Johnson
Johnson & Johnson
$160.66
$1.02 (0.64 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
AbbVie Inc.
AbbVie Inc.
$185.19
$3.02 (1.66 %)
Novartis AG
Novartis AG
$110.28
$0.35 (0.32 %)
Merck & Co. Inc.
Merck & Co. Inc.
$125.30
$-0.55 (-0.44 %)
Johnson & Johnson
Johnson & Johnson
$160.66
$1.02 (0.64 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00